High Science Pin 
A powerful group of anti-drug, law enforcement, and religious organizations is making a last-minute push to stop marijuana reform at the federal level. In a formal letter to former President Donald Trump, these groups are urging him to oppose the Biden administration’s plan to reschedule marijuana from a Schedule I drug to Schedule III.
Their argument centers on two major concerns: public health and tax policy. These groups say that if cannabis is moved to a lower classification, it will allow marijuana companies to claim tax deductions like other legal businesses—a benefit they believe will reward the cannabis industry while putting youth and communities at risk.
Right now, marijuana is classified as a Schedule I substance—alongside heroin and LSD—meaning it’s considered to have no accepted medical use and a high potential for abuse. But that classification is outdated. Dozens of states now recognize the medical use of marijuana, and millions of patients rely on it for pain, anxiety, epilepsy, and more. Rescheduling to Schedule III wouldn’t make cannabis fully legal, but it would acknowledge its medical value and reduce barriers to research, banking, and taxes.
Still, the groups behind the letter argue that any step toward federal acceptance is dangerous. They say rescheduling could normalize marijuana use among youth, reduce stigma around THC and CBD products, and give the appearance that cannabis is completely safe—despite scientific evidence of misuse or dependence in some cases.
Law enforcement groups also claim that rescheduling could weaken their ability to enforce drug laws and prosecute illegal activity. Religious organizations are adding moral pressure, warning that society should not embrace cannabis as a common or “healthy” lifestyle choice.
What these groups may be missing is that rescheduling does not equal legalization. It does not allow people to smoke marijuana wherever they want. It does not override state laws. And it certainly does not remove all regulation around cannabis, hemp, THC, or CBD products. Instead, rescheduling opens the door for more medical studies, a fairer tax system, and clearer guidelines for a legal industry that already exists in much of the country.
Public support for marijuana reform continues to grow. Most Americans support legalization for medical or adult use. Many view cannabis as safer than alcohol or opioids—and research backs that up. States with legal cannabis often report lower opioid deaths, reduced arrests, and better tax revenue that funds education, public health, and social programs.
Efforts to stop progress now—especially through fear-based messaging—ignore the voices of patients, doctors, entrepreneurs, and families who have seen the benefits of cannabis firsthand.
At High Science, we believe education is the path forward. We support safe, legal, and responsible access to cannabis and hemp-based products. We believe in honest dialogue, smart regulation, and protecting public health without feeding into outdated stigma. Whether through cannabis clothing, marijuana wellness, or high-quality information, we stand for reform that works—for everyone.
This latest letter to Trump is a reminder: not everyone is ready to move forward. But the cannabis movement isn’t going away. With every new study, every small business, every patient who finds relief—we are proving the plant’s value one step at a time.
For more on topics like these, check this link out LATEST INDUSTRY NEWS
